The applications of anti-CD20 antibodies to treat various B cells disorders-Reference-Cited by-同舟云学术

The applications of anti-CD20 antibodies to treat various B cells disorders

Published:2019-01 Issue: Volume:109 Page:2415-2426
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Payandeh Zahra,Bahrami Armina Alagheband,Hoseinpoor Reyhaneh,Mortazavi Yousef,Rajabibazl Masoumeh,Rahimpour Azam,Taromchi Amir Hossein^ORCID,Khalil Saeed

Funder

Biotechnology Development Council of the Islamic Republic of Iran

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference133 articles.

1. Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains;Einfeld;EMBO J.,1988

2. Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes;Tedder;Proc. Natl. Acad. Sci.,1988

3. Phosphorylation of the B1 (CD20) molecule by normal and malignant human B lymphocytes;Tedder;J. Biol. Chem.,1988

4. Characterization of two novel pre-B-cell lines (LK63 and LiLa-1): potential models of pre-B-cell differentiation;Salvaris;Leuk. Res.,1992

5. CD20 role in pathophysiology of Hodgkin’s disease;Santos;Revista da Associação Médica Brasileira,2017

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of polyethylene glycol-modified gold nanoparticles for the delivery of Lutetium-177- radiopharmaceuticals based on antibodies;Journal of Drug Delivery Science and Technology;2024-10

2. Novel insights: crosstalk with non-puerperal mastitis and immunity;Frontiers in Immunology;2024-08-01

3. Polatuzumab vedotin combined with bendamustine and rituximab for relapsed/refractory diffuse large B-cell lymphoma: A systematic review protocol;PLOS ONE;2024-08-01

4. Evaluating the Therapeutic Potential of Ublituximab in the Treatment of MS: Design, Development and Place in Therapy;Drug Design, Development and Therapy;2024-07

5. Dental Adverse Effects of Anti-CD20 Therapies;Neurology and Therapy;2024-04-26